Akari Therapeutics Plc logo

Akari Therapeutics Plc Share Price Today

(NASDAQ: AKTX)

Akari Therapeutics Plc share price is $1.21 & ₹103.41 as on 18 Apr 2025, 2.30 'hrs' IST

$1.21

0.1

(9.55%)

Market is closed - opens 7 PM, 21 Apr 2025

View live Akari Therapeutics Plc share price in Dollar and Rupees. Guide to invest in Akari Therapeutics Plc stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Akari Therapeutics Plc, along with analyst recommendations, forecasts, and comprehensive financials.

Akari Therapeutics Plc share price movements

  • Today's Low: $1.10
    Today's High: $1.26

    Day's Volatility :12.91%

  • 52 Weeks Low: $0.85
    52 Weeks High: $4.40

    52 Weeks Volatility :80.68%

Akari Therapeutics Plc (AKTX) Returns

PeriodAkari Therapeutics PlcIndex (Russel 2000)
3 Months
-6.59%
0.0%
6 Months
-44.21%
0.0%
1 Year
3.33%
0.0%
3 Years
-94.94%
-12.9%

Akari Therapeutics Plc (AKTX) Key Statistics

in dollars & INR

Previous Close
$1.1
Open
$1.1
Today's High
$1.263
Today's Low
$1.1
Market Capitalization
$31.9M
Today's Volume
$17.3K
52 Week High
$4.4
52 Week Low
$0.85
Revenue TTM
$0.0
EBITDA
$-16.6M
Earnings Per Share (EPS)
$-2.58
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-179.92%

How to invest in Akari Therapeutics Plc Stock (AKTX) from India?

It is very easy for Indian residents to invest directly in Akari Therapeutics Plc from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Akari Therapeutics Plc stock in both Indian Rupees (INR) and US Dollars (USD). Search for Akari Therapeutics Plc or AKTX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Akari Therapeutics Plc or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Akari Therapeutics Plc shares which would translate to 0.706 fractional shares of Akari Therapeutics Plc as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Akari Therapeutics Plc, in just a few clicks!

Returns in Akari Therapeutics Plc (AKTX) for Indian investors in Rupees

The Akari Therapeutics Plc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Akari Therapeutics Plc investment value today

Current value as on today

₹1,05,760

Returns

₹5,760

(+5.76%)

Returns from Akari Therapeutics Plc Stock

₹3,419 (+3.42%)

Dollar Returns

₹2,341 (+2.34%)

Indian investors sentiment towards Akari Therapeutics Plc (AKTX)

117%

Period: Mar 19, 2025 to Apr 18, 2025. Change in 30 Days versus previous period

Search interest for Akari Therapeutics Plc Stock from India on INDmoney has increased by 117% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Akari Therapeutics Plc

  • Palo Alto Investors, LLC

    0.55%

  • Omnia Family Wealth, LLC

    0.33%

  • HPM Partners LLC

    0.09%

  • Renaissance Technologies Corp

    0.09%

  • Cresset Asset Management, LLC

    0.07%

  • Accent Capital Management LLC

    0.04%

Analyst Recommendation on Akari Therapeutics Plc

Rating
Trend

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Akari Therapeutics Plc(by analysts ranked 0 to 5 stars)

Analyst Forecast on Akari Therapeutics Plc Stock (AKTX)

What analysts predicted

Upside of 6511.57%

Target:

$80.00

Current:

$1.21

Insights on Akari Therapeutics Plc Stock (Ticker Symbol: AKTX)

  • Price Movement

    In the last 3 years, AKTX stock has moved down by -95.4%
  • AKTX vs ONC (1 yr)

    In the last 1 year, Beone Medicines Ltd has given 76.1% return, outperforming this stock by 81.8%
  • AKTX vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 28.9% return, outperforming this stock by 124.3%

Akari Therapeutics Plc Technicals Summary

Sell

Neutral

Buy

Akari Therapeutics Plc is currently in a neutral trading position according to technical analysis indicators.

Akari Therapeutics Plc (AKTX) Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Akari Therapeutics Plc logo
-26.67%
-44.21%
3.33%
-94.94%
-96.23%
Regeneron Pharmaceuticals, Inc. logo
-17.1%
-41.85%
-37.2%
-21.74%
-0.85%
Beone Medicines Ltd logo
-13.12%
5.03%
78.34%
40.23%
43.44%
Vertex Pharmaceuticals Incorporated logo
-4.76%
2.3%
24.05%
71.43%
78.99%
Alnylam Pharmaceuticals, Inc. logo
-9.09%
-19.67%
62.43%
39.66%
61.91%

About Akari Therapeutics Plc

Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on developing advanced therapies for autoimmune and inflammatory diseases. Its lead product candidate is nomacopan, a second-generation complement inhibitor that prevents inflammatory and prothrombotic activities. The company also develops PASylated-nomacopan, which is in preclinical development for the treatment of geographic atrophy secondary to dry age-related macular degeneration; and hematopoietic stem cell transplant-related thrombotic microangiopathy (HSCT-TMA) combined with nomacopan, which is in phase 3 clinical development for the treatment of pediatric HSCT-TMA. The company is headquartered in Boston, Massachusetts.
Organization
Akari Therapeutics Plc
Employees
0
CEO
Dr. Satyajit Mitra Ph.D.
Industry
Health Technology

Management People of Akari Therapeutics Plc

NameTitle
Dr. Satyajit Mitra Ph.D.
Executive Director & Head of Oncology

Important FAQs about investing in AKTX Stock from India :

What is Akari Therapeutics Plc share price today?

Akari Therapeutics Plc share price today stands at $1.21, Open: $1.10 ; Previous Close: $1.10 ; High: $1.26 ; Low: $1.10 ; 52 Week High: $4.40 ; 52 Week Low: $0.85.

The stock opens at $1.10, after a previous close of $1.10. The stock reached a daily high of $1.26 and a low of $1.10, with a 52-week high of $4.40 and a 52-week low of $0.85.

Can Indians buy Akari Therapeutics Plc shares?

Yes, Indians can invest in the Akari Therapeutics Plc (AKTX) from India.

With INDmoney, you can buy Akari Therapeutics Plc at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Akari Therapeutics Plc at zero transaction cost.

How can I buy Akari Therapeutics Plc shares from India?

It is very easy to buy Akari Therapeutics Plc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Akari Therapeutics Plc (AKTX) be purchased?

Yes, you can buy fractional shares of Akari Therapeutics Plc with INDmoney app.

What are the documents required to start investing in Akari Therapeutics Plc stocks?

To start investing in Akari Therapeutics Plc, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Akari Therapeutics Plc Stock (AKTX)?

Today’s highest price of Akari Therapeutics Plc (AKTX) is $1.26.

Today’s lowest price of Akari Therapeutics Plc (AKTX) is $1.10.

What is today's market capitalisation of Akari Therapeutics Plc?

Today's market capitalisation of Akari Therapeutics Plc AKTX is 31.9M

What is the 52 Week High and Low Range of Akari Therapeutics Plc Stock (AKTX)?

  • 52 Week High

    $4.40

  • 52 Week Low

    $0.85

What are the historical returns of Akari Therapeutics Plc (AKTX)?

  • 1 Month Returns

    -26.67%

  • 3 Months Returns

    -44.21%

  • 1 Year Returns

    3.33%

  • 5 Years Returns

    -96.23%

Who is the Chief Executive Officer (CEO) of Akari Therapeutics Plc ?

Dr. Satyajit Mitra Ph.D. is the current Chief Executive Officer (CEO) of Akari Therapeutics Plc.